课题基金基金详情
Nucleolin在乙肝病毒cccDNA小染色体转录过程中的调控机制研究
结题报告
批准号:
81971936
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
夏宇尘
依托单位:
学科分类:
肝炎病毒与感染
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
夏宇尘
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
乙肝病毒的感染是严重的社会健康威胁。在感染肝细胞后,病毒在细胞核内生成一个共价闭合环状的小染色cccDNA作为病毒基因转录和复制的模板。cccDNA持续稳定存在于被感染肝细胞中,而目前所有药物无法有效的将它清除。因此,研究cccDNA小染色体、鉴定相关宿主蛋白不仅有助于了解病毒的生物学基础,还有助于研发针对cccDNA的新型抗病毒药物来治愈乙肝病毒感染。通过建立体外高效感染模型,我们分离纯化并鉴定了cccDNA相关宿主蛋白,发现了Nucleolin(核仁素)作为新的病毒感染关键因子。我们前期研究结果发现Nucleolin能与cccDNA启动子区结合调控其转录。本课题拟过ChIP-Seq、基因敲除、免疫共沉淀、邻位连接技术等方法全面系统探索Nucleolin调控HBV cccDNA转录的分子机制并在HBV病人肝穿样本中验证,以期将Nucleolin作为药物靶点筛选新的抗病毒药物。
英文摘要
Hepatitis B virus (HBV) remains a major public health threat worldwide. After infection, the virus infects hepatocytes and establishes a covalently closed circular DNA (cccDNA) mini-chromosome, which serves as the transcriptional template of viral replication, in the nucleus of infected cells. Its stability accounts for the long-term persistence of HBV even if viral replication is blocked by antivirals. Currently, none of the treatments have significant little or no impact on eliminating HBV infection cccDNA. Therefore, identification of cccDNA- associated host factors and their functions is not only important in understanding the basic biology of HBV but also relevant to designing novel strategies to target cccDNA for potential curative therapy. Based on the efficient in vitro infection model, we isolated and purified cccDNA associated host proteins, and identified Nucleolin as a key factor of HBV infection. Our preliminary data showed that Nucleolin binds to the promoter regions of HBV cccDNA and regulates its transcription. We will use different methods including ChIP-Seq, gene knockout, Co-Immunoprecipitation, proximity ligation assay to dissect the molecular mechanism of how Nucleolin regulate HBV cccDNA and further validate our findings in liver biopsies from chronic hepatitis B patients. Whether Nucleolin is a potential target for antiviral development will also be evaluated.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
LINC01431 Promotes Histone H4R3 Methylation to Impede HBV Covalently Closed Circular DNA Transcription by Stabilizing PRMT1.
LINC01431 通过稳定 PRMT1 促进组蛋白 H4R3 甲基化以阻碍 HBV 共价闭合环状 DNA 转录
DOI:10.1002/advs.202103135
发表时间:2022-05
期刊:Advanced science (Weinheim, Baden-Wurttemberg, Germany)
影响因子:--
作者:
通讯作者:
DOI:10.1371/journal.ppat.1011382
发表时间:2023-05
期刊:PLoS pathogens
影响因子:6.7
作者:
通讯作者:
DOI:10.1038/s42255-023-00808-9
发表时间:2023-05
期刊:Nature Metabolism
影响因子:20.8
作者:Shiguan Wang;Shanze Chen;Jianfeng Sun;Pan Han;Bowen Xu;Xinying Li;Youquan Zhong;Zaichao Xu;P. Zhang;Ping Mi;Cuijuan Zhang;Lixiang Li;Haiyan Zhang;Yuchen Xia;Shi-yu Li;Mathias Heikenwalder;Detian Yuan
通讯作者:Shiguan Wang;Shanze Chen;Jianfeng Sun;Pan Han;Bowen Xu;Xinying Li;Youquan Zhong;Zaichao Xu;P. Zhang;Ping Mi;Cuijuan Zhang;Lixiang Li;Haiyan Zhang;Yuchen Xia;Shi-yu Li;Mathias Heikenwalder;Detian Yuan
DOI:10.1128/jvi.01362-22
发表时间:2022-10
期刊:Journal of Virology
影响因子:5.4
作者:Youquan Zhong;Chuanjian Wu;Zaichao Xu;Yan Teng;Li Zhao;Kaitao Zhao;Jingjing Wang;Wen Wang;Qiong Zhan;Chengliang Zhu;Xinwen Chen;Kaiwei Liang;Xiaoming Cheng;Yuchen Xia
通讯作者:Youquan Zhong;Chuanjian Wu;Zaichao Xu;Yan Teng;Li Zhao;Kaitao Zhao;Jingjing Wang;Wen Wang;Qiong Zhan;Chengliang Zhu;Xinwen Chen;Kaiwei Liang;Xiaoming Cheng;Yuchen Xia
DOI:10.1002/hep.32622
发表时间:2022-06
期刊:Hepatology
影响因子:13.5
作者:Kaitao Zhao;Fangteng Guo;Jingjing Wang;Youquan Zhong;J. Yi;Yan Teng;Zaichao Xu;Li Zhao;Aixin Li;Zichen Wang;Xinwen Chen;Xiaoming Cheng;Yuchen Xia
通讯作者:Kaitao Zhao;Fangteng Guo;Jingjing Wang;Youquan Zhong;J. Yi;Yan Teng;Zaichao Xu;Li Zhao;Aixin Li;Zichen Wang;Xinwen Chen;Xiaoming Cheng;Yuchen Xia
国内基金
海外基金